LGVN
Price
$1.52
Change
-$0.02 (-1.30%)
Updated
Jul 18 closing price
Capitalization
22.81M
QURE
Price
$14.90
Change
-$0.09 (-0.60%)
Updated
Jul 21, 10:42 AM (EDT)
Capitalization
820.68M
10 days until earnings call
Interact to see
Advertisement

LGVN vs QURE

Header iconLGVN vs QURE Comparison
Open Charts LGVN vs QUREBanner chart's image
Longeveron
Price$1.52
Change-$0.02 (-1.30%)
Volume$322.5K
Capitalization22.81M
uniQure
Price$14.90
Change-$0.09 (-0.60%)
Volume$701
Capitalization820.68M
LGVN vs QURE Comparison Chart in %
Loading...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
LGVN vs. QURE commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LGVN is a Hold and QURE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (LGVN: $1.52 vs. QURE: $14.99)
Brand notoriety: LGVN and QURE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LGVN: 83% vs. QURE: 147%
Market capitalization -- LGVN: $22.81M vs. QURE: $820.68M
LGVN [@Biotechnology] is valued at $22.81M. QURE’s [@Biotechnology] market capitalization is $820.68M. The market cap for tickers in the [@Biotechnology] industry ranges from $286.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LGVN’s FA Score shows that 1 FA rating(s) are green whileQURE’s FA Score has 0 green FA rating(s).

  • LGVN’s FA Score: 1 green, 4 red.
  • QURE’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than QURE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LGVN’s TA Score shows that 7 TA indicator(s) are bullish while QURE’s TA Score has 6 bullish TA indicator(s).

  • LGVN’s TA Score: 7 bullish, 2 bearish.
  • QURE’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than QURE.

Price Growth

LGVN (@Biotechnology) experienced а +7.04% price change this week, while QURE (@Biotechnology) price change was +4.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

QURE is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QURE($821M) has a higher market cap than LGVN($22.8M). LGVN YTD gains are higher at: -12.139 vs. QURE (-15.119). LGVN has higher annual earnings (EBITDA): -16.49M vs. QURE (-138.01M). QURE has more cash in the bank: 409M vs. LGVN (14.3M). LGVN has less debt than QURE: LGVN (1.3M) vs QURE (66.2M). QURE has higher revenues than LGVN: QURE (20.2M) vs LGVN (2.23M).
LGVNQURELGVN / QURE
Capitalization22.8M821M3%
EBITDA-16.49M-138.01M12%
Gain YTD-12.139-15.11980%
P/E RatioN/AN/A-
Revenue2.23M20.2M11%
Total Cash14.3M409M3%
Total Debt1.3M66.2M2%
FUNDAMENTALS RATINGS
QURE: Fundamental Ratings
QURE
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
91
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LGVNQURE
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
81%
MACD
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 4 days ago
87%
Advances
ODDS (%)
Bullish Trend 19 days ago
82%
Bullish Trend 5 days ago
75%
Declines
ODDS (%)
N/A
Bearish Trend 25 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
76%
View a ticker or compare two or three
Interact to see
Advertisement
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QURE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SYY78.410.50
+0.64%
Sysco Corp
BFS32.88-0.12
-0.36%
Saul Centers
CBZ74.70-0.50
-0.66%
CBIZ
GNFT3.79-0.05
-1.17%
Genfit SA
GVH0.04-0.01
-25.32%
Globavend Holdings Limited

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with PROK. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-1.30%
PROK - LGVN
39%
Loosely correlated
-10.51%
QURE - LGVN
38%
Loosely correlated
-1.38%
SNGX - LGVN
36%
Loosely correlated
+0.74%
TECH - LGVN
34%
Loosely correlated
-2.38%
NTLA - LGVN
33%
Loosely correlated
+1.94%
More

QURE and

Correlation & Price change

A.I.dvisor indicates that over the last year, QURE has been loosely correlated with NAMS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if QURE jumps, then NAMS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QURE
1D Price
Change %
QURE100%
-1.38%
NAMS - QURE
51%
Loosely correlated
+1.00%
BEAM - QURE
47%
Loosely correlated
+1.47%
HOOK - QURE
46%
Loosely correlated
N/A
CRDF - QURE
44%
Loosely correlated
-3.82%
NRIX - QURE
42%
Loosely correlated
-7.28%
More